Recent evidence [Surridge and Burns, Biochemistry (1994) 33, 805 1-80571 on the interaction of native and recombinant tau, recombinant MAP2c, and native MAP2 with vesicles prepared from phosphatidylinositol (PtdIns) and other phospholipids demonstrate that MAP2 differs from MAP2c and from tau in having a high-affinity PtdIns-binding site. The location of this site within the MAP2-specific insert peptide, coupled with considerations of the nature of the MAP2 tubulin-binding site, suggests that PtdIns-binding induces a conformational change which alters the MAP2 tubulin-binding domain. Furthermore, the restricted cellular distribution of MAP2 implies that the MAP2:PtdIns interaction may play a central role in modulating the dendritic cytoskeleton.
Introduction
Immunological and other cytological studies have established that axons and dendrites contain different subsets of the microtubule-associated proteins (MAPs). In particular, the 200 kDa MAP2 is present in dendrites and dendritic processes while MAP2c, a differential splice product of the MAP2 gene which is selectively expressed during early development, is present in both axons and dendrites [ 1-31. Furthermore, members of the tau family of MAPs are preferentially localized within the axons and are largely absent from dendrites and dendritic processes (e.g. [ 31) . Consequently, properties exhibited by MAP2 but by neither MAP2c nor the tau proteins may be important as far as the dendritic cytoskeleton is concerned, whereas properties which are only exhibited by the tau proteins may relate to an axon-specific function.
MAP2c differs from MAP2 by the deletion, for the mouse sequence, of a 1372-residue internal peptide ([4-61, Figure 1 ). MAP2 and MAP2c therefore share common N-and C-terminal peptides (1-147 and 1519-1828 for the mouse sequence). 'The C-terminal peptide includes the tubulin-bindAbbreviations used: MAP, microtubule-associated protein including such proteins as MAP2, MAP2c, and the tau isoforms; PtdCho, phosphatidylcholine; PtdIns, phosphatidylinositol; PtdSer, phosphatidylserine. *To whom correspondence should be addressed.
Figure I
The primary structures of MAP2, MAP2c and tau, showing that MAP2 and MAP2c share common Nand C-terminal peptides, but that MAP2c lacks the extensive MAP2 insert peptide
The C-terminal peptide of MAP2 (and MAPc) shows some sequence similarity t o that of tau In particular, the three proteins each have three or four 18-residue quasi-repeats [41, 42] which are highly homologous to each other [7, 8] These repeats are separated by somewhat more divergent 'spacer' peptides In addition, MAP2 (and MAP2c) and tau each have a (non-identical) proline-rich peptide N-terminal t o the quasirepeats, and a protease-sensitive site Cleavage at this site divides MAP2, MAP2c and tau into two structural domains, the C-terminal of which binds to assembled microtubules [28.32,33,36.37] Most of the phosphorylation sites labelled by the cyclic AMP-activated protein kinase map to the C-terminal fragment [43] , which also contains the binding sites for estramustine phosphate [21, 24] ! N-1
ing domain, which is highly homologous to the equivalent peptides of the tau proteins and the widely expressed MAP4 (see [7, 8] ). These tubulinbinding sequences are characterized by (a) being highly cationic; (b) having, as a result of differential gene splicing, either three or four 18-residue quasirepeats, each separated by more divergent 'spacer' peptides; (c) having a proline-rich peptide which lies N-terminal to the tandem repeats; and (d) having a proteolytic-sensitive site which divides the MAP molecules into two domains, one which binds to microtubules and promotes microtubule assembly and a second which forms a projecting 'side-arm'. The properties of this tubulin-binding domain have been extensively studied, using both native MAP2 and tau, synthetic peptides of both the MAP2 and tau sequences, and by expressing fulllength and progressively truncated constructs of both the MAP2 and tau genes. In summary, there is strong evidence that the microtubule-binding activity of MAP2, MAP2c, MAP4, and the tau isoforms results from a number of weak but incremental
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interactions which are dispersed along about 140 residues (for the 4-repeat isoforms, and including contributions from the proline-rich peptide) of the C-terminal peptides (e.g. [9] ), although there is some dissent about which peptides are the most important (e.g. [9] versus [ lo]). Furthermore, this model is consistent with the incremental reduction in the affinity of MAP2 for the microtubule lattice by increasing levels (0-12 mol*mol-') of phosphorylation by the co-purifying cyclic AMP-activated protein kinase [11, 12] , and by the effects of this phosphorylation on the promotion of microtubule assembly by both MAP2 and tau [12, 13] . Such studies, together with the variation in the number of tandem repeats, have suggested that MAP2, tau, and MAP4 promote microtubule assembly by 'lacquering' the surface lattice [lo] , so reducing the anionic surface charge associated with the C-terminal peptides of the a-and B-tubulin subunits. This low-affinity 'lacquering' mechanism may also account for the observed gelation of actin filaments [14] [15] [16] [17] , even though actin and tubulin share minimal sequence similarity. Indeed, gelation is effected by MAP2, tau, and one of the shared tandem repeats [18] , and it is inhibited, in common with microtubule assembly, by the level of phosphorylation of MAP2 by the cyclic AMP-activated protein kinase [ 16,191. MAP-dependent microtubule assembly is specifically inhibited by two ligands: estramustine phosphate [25-281. Microtubule assembly studies and direct ligand-binding assays indicate that estramustine phosphate binds to multiple (3-6) sites on MAP2 with an apparent Kd of -20 p M [22, 23] . These sites may correspond to the tandem repeats of the C-terminal peptide [22, 24] . The effects of estramustine phosphate are therefore similar to those resulting from the multiple phosphorylation by the cyclic AMP-activated protein kinase, and support the general model that the promotion of microtubule assembly by the MAP C-terminal peptide is due to charge neutralization, and that any reduction in the cationic nature of the C-terminal peptide reduces its assembly-promoting ability.
It is more difficult to reconcile this model with the evidence that PtdIns inhibits microtubule assembly, and actin gelation [27] , by binding to a single high-affinity site on MAP2 [26] . MAPdependent microtubule assembly is also inhibited by other phospholipids [e.g. 25,261, but studies of the inhibition by phosphatidylcholine (PtdCho) vesicles doped with such phospholipids have clearly shown that only PtdIns binds to a specific highaffinity site (& < 1 p M MAP2, [26] ). More recent work, which is summarized here, has established that there is a low-affinity interaction (apparent Kd 1.5-2.5 pM) between PtdIns and the highly cationic C-terminal peptide of MAP2, MAP2c and tau, and an additional high-affinity (apparent K , -22 1 nM) interaction between PtdIns and the MAP2 insert peptide, such that the apparent MAP2:PtdIns Kd is reduced to -5 1 f 6 nM MAP2 [28] . These binding studies strongly suggest that the MAP2 tubulin-(and actin-)binding site may have a more complex structure than previously proposed and may undergo a conformational change in response to PtdIns-binding, and that PtdIns-binding may be of considerable importance to the physiological control of the dendritic cytoskeleton.
Methods
Native MAP2 was purified from bovine microtubule protein by phosphocellulose chromatography while native bovine tau was purified directly from bovine brain by heat denaturation and DEAEcellulose chromatography [28] . Clones expressing murine MAP2c or human tau (PET NCO/MAP2c and pRK172 4RT/383; generous gifts from Drs. Andrew Matus and Michel Goedert) were grown in Escherichia coli, and the over-expressed proteins purified by fractionation on carboxymethyl-Sepharose [28, 29] . The binding of these purified MAPS to phospholipid vesicles was assayed by incubating (10 min, 20°C) increasing concentrations (0-50 nM) of the clarified (I00000 g, 30min) proteins with vesicles in MEM (100 mM Mes, 2.5 mM EGTA, 0.5 mM MgCI?, 0.1 mM EDTA, 1 mM dithiothreitol, pH 6.4, with KOH) buffer containing a final concentration of 67mM NaCI, and then pelleting the vesicles (100 000 g, 30 min). The bound protein was quantified by colloidal gold dot blotting (see [28] ), and used to derive Scatchard plots from which the apparent dissociation constants and the attached S.D. values were calculated by weighted leastsquare regression.
Results
The apparent Kds of native bovine tau and recombinant human tau383 to PtdIns vesicles are 2.4 k 0.6 and 1.6 & 0.2 p M tau respectively (Table 1 ). The small difference between the apparent Kds probably reflects the isoform heterogeneity of the native protein compared with the four-repeat recombinant isoform [29] , or to phosphorylation of the native protein by the neuronal cyclic AMP-activated protein kinase. The apparent & of PtdIns binding to recombinant MAP2c is 1.4 k 0.1 pM MAP2c ( Table   Volume 23 The similarity of the K d S for PtdIns binding to tau and MAP2c (1.4-2.4pM) suggests that these values reflect an interaction between the pure PtdIns vesicles and the highly homologous C-terminal peptides, and that the tighter binding of the native MAP2 (51 nM) involves an additional interaction with a site located within the MAP2-specific peptide (see Figure 1 ). Such a model would be consistent with the previous studies [26] which had shown (a) that vesicles prepared from various pure phospholipids, such as phosphatidylserine (PtdSer), inhibit microtubule assembly, but that this binding required a high local concentration of the phospholipid; and (b) that only PtdIns is inhibitory at the low local concentrations obtained by doping PtdCho vesicles.
The binding of native bovine MAP2 and recombinant murine MAP2c to PtdSer vesicles yielded apparent Kd values of 1.3 f 0 . 3 and 1.8 k 0.2 p M respectively (Table 1) . This strongly suggests, as pure PtdSer vesicles inhibit microtubule assembly [25, 26] , that the low-affinity, nonspecific interaction involves the cationic C-terminal peptide, and that the comparable apparent Kds for the observed binding of tau and MAP2c to PtdIns vesicles reflects this non-specific interaction. Indeed, the C-terminal peptide of MAPZc, prepared by thrombin digestion of the recombinant protein, binds to PtdIns vesicles [28] . As this low-afinity interaction requires a high local concentration of the phospholipid, it would not be detected using the doped vesicle assay. Indeed, no binding of either tau or MAP2c was detected to PtdCho vesicles doped with PtdIns to a ratio of 1:9 PtdIns/PtdCho. By contrast, native MAP2 bound to PtdIns-doped PtdCho vesicles (1 :SO0 PtdIns/PtdCho) with an apparent Kd of 2 2 1 f 2 5 n M MAP2 (Table 1) .
Lower levels of doping resulted in apparent Kds which were intermediate between this and the 51 nM values, while higher levels of doping (up to 1:lOOO) resulted in no additional increase in the apparent Kd. Consequently, the observed binding of MAP2 to the PtdIns/PtdCho-doped vesicles (1 :500) reflects the Kd of the second, high-affinity, PtdIns-specific site which is peculiar to the native MAP2
Discussion
The binding of tau and MAP2c to pure PtdIns vesicles and the binding of MAP2c and MAP2 to PtdSer vesicles have apparent Kds in the 1.2-2.4pM range, while MAP2 binds to pure PtdIns vesicles with an apparent Kd of 5 1 k 6 nM and to PtdIns-doped PtdCho vesicles with an apparent Kd of 221 k 25 nM (see Table 1 ). These results, together with the binding of the C-terminal peptide of MAP2c to pure PtdIns vesicles, strongly suggests that the observed binding of MAP2 to PtdIns vesicles reflects the cumulative effects of two interactions: (a) a non-specific interaction associated with the highly cationic C-terminal peptide 43 common to tau, MAP2 and MAPZc, which contributes a binding energy equivalent to a Kd of approx. 1.5-2.5 pM; and (b) a PtdIns-specific interaction at a site which is localized within the MAP2-specific insert peptide (see Figure I ), which has an apparent K , of 221 f 25 pM (Table l) , and which is detected when PtdIns is dispersed within a nonbinding environment. PtdIns binding to this site may account for the selective inhibition by PtdIns of MAP2-, but not tau-, induced actin gelation [27] . It is however surprising that actin gelation is apparently unaffected by the interaction between the pure PtdIns vesicles and the cationic C-terminal peptide of the tau protein.
One unexpected feature of this dual interaction of MAP2 with PtdIns is that the apparent A G for binding to pure PtdIns vesicles ( -41.6 kJ.mol-I ) is considerably less than the additive contributions from the two separate sites ( -37.9 kJmol-' and --32.5 kJ.mol-I). This contrasts with the additive A G contributions of the individual tandem repeats to the total free energy of tau binding to microtubules [9] . The dual nature of the interaction does, however, present a conundrum, since PtdIns binding to the MAP2-specific insert peptides appears to over-ride the tubulin-binding activity dispersed along the C-terminal peptide. This problem might be resolved if the geometry of the association between this MAP2 site and the PtdIns vesicle resulted in the steric inhibition of the binding of tubulin subunits to the C-terminal peptide. This seems unlikely since the equilibrium between the two competing processes (microtubule assembly and PtdIns binding) will be biased in favour of the microtubule assembly. Specifically, the K , for MAP2 binding to taxol-stabilized microtubules is lower than that of the PtdIns-MAP2 interaction (1 5-50 nM MAP2 in a highly co-operatived process [30] versus 220nM MAP2, Table 1 ) and the concentration of tubulin is significantly higher than that of the PtdIns (typically > 2 p M tubulin for the assembly and -30 nM PtdIns for the 1 : 500 PtdInsdoped PtdCho vesicles, assuming that they are monolayered and that only the exposed surface is available for MAP2 binding).
An alternative explanation might be for the PtdIns binding to the MAP2-specific insert peptide to induce a conformational change within the MAP2 molecule which reduces the affinity of the microtubule-binding site for tubulin subunits. The dispersed nature of the microtubule-binding site means that such a conformational change would have to specifically affect that part of the microtubule-binding site which contributes most to the tubulin-binding activity. The target of this conformational change may be one of the 18-residue tandem repeats or a 'spacer' peptide, since the second repeat of MAP2 has the greatest effect in promoting microtubule assembly [ 3 1,321 while the first repeat of tau (or the Rl/R2 'spacer' peptide) contributes most to the binding energy [9, 10] and the phosphorylation of tau :Ser2''Z (of repeat 1) markedly affects the promotion of microtubule assembly [33] .
The proposed change in the conformation of MAP2 may be related to the extraordinary elasticity of the tau protein, as illustrated by the 3-fold variation in the paracrystalline periodicities [ 341, since the reported length of the MAP2 molecule varies widely (90-185 nm .
The measured PtdIns-MAP2 dissociation constants provide some indirect support for this conformational interpretation. The A G from two independent, but spatially adjacent, PtdIns-binding sites should equal the sum of the contributions from the two sites, yet the observed A G for binding to pure PtdIns vesicles ( -4 1.6 kJmol-') differs markedly from the summed value ( --70 kJ*mol-').
Knowledge of the independent dissociation constants permits the distance between the independent sites to be calculated, assuming that they are separated by a flexible linkage [ 381. Calculating this distance for the two PtdIns-binding sites of MAP2 implies that they are separated by 580 nm, i.e. 3-fold further apart than the highest estimates of the length of the MAP2 molecule. The contribution of the C-terminal peptide is therefore much less than that predicted from the apparent Kds (1.5-2.5 pM MAP2 for the binding to pure PtdIns or pure PtdSer vesicles, Table 1 ). Further evidence that a simple 'lacquering' mechanism fails to account for the observed properties of MAP2 comes from the finding that the salt sensitivity of the binding to MAP2 to immobilized actin or tubulin depends upon whether the salt is added before or after the MAP2 is bound to the target proteins [ 171.
The mechanism by which PtdIns binding to the high-affinity site influences the binding of tubulin (and actin) remains to be elucidated, but may prove to be central to any understanding of the physiological role of the PtdIns-MAP2 interaction. Such a physiological role is clearly indicated by both the endogenous character of the ligand and by the tightness of the PtdIns-MAP2 interaction, while the MAP2 localization studies indicate any functional role will involve dendrites rather than axons. The in vitro studies imply that a fraction of the dendritic MAP2 may be associated in vivo with one or more classes of membrane, yet inspection of the Volume 23 modulate the ability of MAP2 to promote microtubule assembly and to gelate actin filaments. This may be analogous with the modulation resulting from the interaction between PtdInsP, and various actin-binding proteins, including profilin and gelsolin (e.g. [40] ). Studies of both amoeboid movement and phagocytosis show that the activation of a transmembrane receptor leads, via a G-protein cascade, to the activation of a phospholipase, which in turn hydrolyses PtdInsP,, the release of the bound proteins, and the consequential effects on the subcortical actin gel. By analogy, the activation of a transmembrane receptor might lead, via a G-protein cascade, to the activation of a phospholipase, to the hydrolysis of PtdIns, and to the release of MAP2 from the plasmamembrane (Figure 2 ). The restricted distribution of MAP2 would mean that this process would be restricted to dendrites and to dendritic processes, while the in vitro evidence would suggest that an elevation in the concentration of available MAP2 would lead to enhanced actin gelation and to the promotion of microtubule assembly. Consequently, the activation of a trans-membrane receptor would lead to a reorganization of the dendritic cytoskeleton. This reorganization would be likely, within the confines of the brain, to be a response to a signal originating from a second neuronal cell. The MAP2-PtdIns interaction may therefore be a key step in the process by which extracellular signals modulate dendritic wiring, and contribute to the process of learning. 
